Rational Development of a Polysaccharide–Protein-Conjugated Nanoparticle Vaccine Against SARS-CoV-2 Variants and Streptococcus pneumoniae (Adv. Mater. 21/2022)
Advanced Materials
; 34(21):2270160, 2022.
Article
in English
| Wiley | ID: covidwho-1866500
ABSTRACT
Nanoparticle Vaccines In article number 2200443, Liangzhi Xie, Chengfeng Qin, and co-workers develop a novel bivalent nanoparticle vaccine that confers protection against infection of multiple SARS-CoV-2 variants and Streptococcus pneumoniae. This universal polysaccharide?protein-conjugated vaccine platform provides a powerful tool to fight against cocirculating viral and bacterial pathogens worldwide.
Full text:
Available
Collection:
Databases of international organizations
Database:
Wiley
Topics:
Vaccines
/
Variants
Language:
English
Journal:
Advanced Materials
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS